An Indian manufacturer's perspective for harmonization of guidelines for similar biotherapeutic products

0Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.

Abstract

This review focuses on the scenario of Indian manufacturers, biotherapeutics approvals in India and important aspects which need to be precisely analyzed and resolved from the Indian perspective to facilitate implementation of global guidelines for the manufacture of these products, to best serve the public health needs of the developing countries. © 2011.

Cite

CITATION STYLE

APA

Babu, P. V. C. (2011). An Indian manufacturer’s perspective for harmonization of guidelines for similar biotherapeutic products. Biologicals, 39(5), 300–303. https://doi.org/10.1016/j.biologicals.2011.06.022

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free